Incidence and Risk Factors for Hospital Readmission or Unexpected Visits in Women Undergoing Unscheduled Cesarean Delivery.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 17 3 2019
medline: 16 7 2020
entrez: 17 3 2019
Statut: ppublish

Résumé

Hospital readmissions are increasingly tracked and assessed for value-based compensation. Our objective was to determine the incidence and risk factors associated with post-cesarean delivery (CD) readmissions or unexpected visits, defined as unexpected office or emergency room visits. This is a secondary analysis of a multicenter randomized controlled trial of adjunctive azithromycin prophylaxis for CD performed in laboring patients with viable pregnancies. Patients were followed up to 6 weeks postpartum. Our primary outcome was a composite of hospital readmission or unexpected visit, defined as unscheduled clinic or emergency department visits. Data of hospital readmissions, unexpected visits, and their reasons were collected. Demographics, antepartum, intrapartum, and postpartum risk factors were evaluated in bivariate analyses and multivariable logistic regression modeling. A total of 1,019 women were randomized to azithromycin and 994 to placebo. The prevalence of readmission or unexpected visit was 10.2% (95% confidence interval [CI]: 8.9-11.6), with rates of 3.8% (95% CI: 3.0-4.7%) hospital readmissions, 6.9% (95% CI: 5.8-8.0%) emergency room visits, and 4.2% (95% CI: 3.4-5.2%) unexpected clinic visits. The most common causes were infectious disease and hypertensive disorder. Women with readmissions or unexpected visits were more likely to be obese and diabetic, as well as experience longer length of ruptured membranes, intrauterine pressure catheter placement, and postpartum fevers. On multivariable analysis, diabetes (adjusted odds ratio [aOR]: 1.6, 95% CI: 1.1-2.4), prolonged ruptured membranes (aOR: 1.9, 95% CI: 1.3-2.8), and postpartum fevers (aOR: 4.6, 95% CI: 3.0-7.0) were significantly positively associated with readmission or unscheduled visit, while azithromycin was a protective (aOR: 0.6, 95% CI: 0.5-0.9). Women who had postpartum fever were at especially high risk for readmission or unexpected visits. Diabetes, prolonged ruptured membranes, and postpartum fevers were significantly associated with the adverse outcome, and azithromycin was associated with lower rates of readmission and unexpected visits.

Identifiants

pubmed: 30877684
doi: 10.1055/s-0039-1683391
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azithromycin 83905-01-5

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1115-1119

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Mauricio La Rosa (M)

Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, Texas.

Victoria Jauk (V)

Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama.

George R Saade (GR)

Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, Texas.

Kim Boggess (K)

Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Sherri Longo (S)

Oshner Health System, New Orleans, Louisiana.

Erin A S Clark (EAS)

Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah.
Intermountain Health-LC, Salt Lake City, Utah.

Sean Esplin (S)

Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah.
Intermountain Health-LC, Salt Lake City, Utah.

Kirsten Cleary (K)

Department of Obstetrics and Gynecology, Columbia University, New York, New York.

Ronald Wapner (R)

Department of Obstetrics and Gynecology, Columbia University, New York, New York.

Kellet Letson (K)

Department of Obstetrics and Gynecology, Mission Hospital, Asheville, North Carolina.

Michelle Y Owens (MY)

Department of Obstetrics and Gynecology, University of Mississippi at Jackson, Jackson, Mississippi.

Sean Blackwell (S)

Department of Obstetrics and Gynecology, University of Houston at Houston, Houston, Texas.

Jeff M Szychowski (JM)

Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama.

William Andrews (W)

Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama.

Alan T Tita (AT)

Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, Birmingham, Alabama.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH